Abstract:Osteoporosis is a major concern worldwide and can be attributed to an imbalance between osteoblastic bone formation and osteoclastic bone resorption due to the natural aging process. Heritable factors account for 60–80% of optimal bone mineralization; however, the finer details of pathogenesis remain to be elucidated. Micro RNA (miRNA) and long-non-coding RNA (lncRNA) are two targets that have recently come into the spotlight due to their ability to control gene expression at the post-transcriptional level and provide epigenetic modification. miRNAs are a class of non-coding RNAs that are approximately 18–25 nucleotides long. It is thought that up to 60% of human protein-coding genes may be regulated by miRNAs. They have been found to regulate gene expression that controls osteoblast-dependent bone formation and osteoclast-related bone remodeling. lncRNAs are highly structured RNA transcripts longer than 200 nucleotides that do not translate into proteins. They have very complex secondary and tertiary structures and the same degradation processes as messenger RNAs. The fact that they have a rapid turnover is due to their sponge function in binding the miRNAs that lead to a degradation of the lncRNA itself. They can act as signaling, decoy, and framework molecules, or as primers. Current evidence suggests that lncRNAs can act as chromatin and transcriptional as well as post-transcriptional regulators. With regards to osteoporosis, lncRNA is thought to be involved in the proliferation, apoptosis, and inflammatory response of the bone. This review, which is based on a systematic appraisal of the current literature, provides current molecular and genetic opinions on the roles of miRNAs and lncRNAs in osteoporosis. Further research into the epigenetic modification and the regulatory roles of these molecules will bring us closer to potential disease-modifying treatment for osteoporosis. However, more issues regarding the detailed actions of miRNAs and lncRNAs in osteoporosis remain unknown and controversial and warrant future investigation.

Role of micro ribonucleicacid in bone remodeling

miRNA regulating the differentiation and function of osteoblasts and osteoclasts

MicroRNAs Regulate Bone Development and Regeneration

The Emerging Role of Micrornas in Bone Remodeling and Its Therapeutic Implications for Osteoporosis

Regulation of osteoclast differentiation by microRNAs

MicroRNAs in maxillofacial bone modeling and remodeling: implications for malocclusion development and orthodontic treatment

The Involvement of microRNAs in Bone Remodeling Signaling Pathways and Their Role in the Development of Osteoporosis

Bone Remodeling Induced by Mechanical Forces is Regulated by Mirnas

Bone Remodeling Induced by Mechanical Forces is Regulated by miRNAs.

Molecular Signaling Pathways and MicroRNAs in Bone Remodeling: A Narrative Review

MiRNAs regulate cell communication in osteogenesis-angiogenesis coupling during bone regeneration

The role of long non‐coding RNAs and circular RNAs in bone regeneration: Modulating miRNAs function

The Role of Micro RNA and Long-Non-Coding RNA in Osteoporosis

Post-Transcriptional Regulatory Crosstalk between MicroRNAs and Canonical TGF-β/BMP Signalling Cascades on Osteoblast Lineage: A Comprehensive Review

MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis

The Role of MicroRNAs in the Osseointegration Process

MicroRNA-21: An Emerging Player in Bone Diseases

The mechanism advance of MicroRNA in cartilage injury and degeneration

Role of miR-155 in jaw bone metabolism

microRNAs in inflammatory alveolar bone defect: A review

Roles of microRNAs in prenatal chondrogenesis, postnatal chondrogenesis and cartilage-related diseases.